Journals / Solunum / 2016 / Cilt: 18 - Sayı: 1

Talc Pleurodesis Through Very-Small-Bore Catheters in Patients with Recurrent Malignant Pleural Effusion

Journal
Solunum
Pages
46–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Talc pleurodesis through 7F or 8F catheters may be performed in selected patients with reduced patient discomfort, and similar success rates that was obtained using higher caliber catheters in the treatment of recurrent MPE

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Malignant pleural effusion (MPE) is a frequent and disturbing complication of metastatic disease.
📊
Key Findings & Data:Talc pleurodesis via percutaneosly placed 12-18F catheters is an effective procedure to treat recurrent MPE.
💡
Conclusion & Impact:Conclusion: Talc pleurodesis through 7F or 8F catheters may be performed in selected patients with reduced patient discomfort, and similar success rates that was obtained using higher caliber catheters in the treatment of recurrent MPE
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Malignant pleural effusion (MPE) is a frequent and disturbing complication of metastatic disease. Talc pleurodesis via percutaneosly placed 12-18F catheters is an effective procedure to treat recurrent MPE. We aimed to determine the efficiency of talc pleurodesis through very-small-bore catheters in the treatment of recurrent malignant pleural effusion. Methods: We performed 13 talc pleurodesis procedures in 10 patients with recurrent MPE via pre-existing 7F (6 patients) and 8F (4 patients) pig-tail catheters. We analyzed technical and clinical success of the procedure.Results: All procedures were performed successfully. Complete or partial clinical success was achieved in 8 out of 10 patients. No major complication was observed. Conclusion: Talc pleurodesis through 7F or 8F catheters may be performed in selected patients with reduced patient discomfort, and similar success rates that was obtained using higher caliber catheters in the treatment of recurrent MPE

🔖

Cite This Article

ÖZGEN, A. (2016). Talc Pleurodesis Through Very-Small-Bore Catheters in Patients with Recurrent Malignant Pleural Effusion. Solunum, Cilt: 18 - Sayı: 1, 46–49. https://ajindex.com/articles/314245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Egan AM, McPhillips D, Sarkar S, Breen DP. Malignant pleural effusion. Q J Med 2014; 107: 179-84. [CrossRef] Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: A meta-analysis. PLoS One 2014; 9: e87060. [CrossRef] Srour N, Amjadi K, Forster A, Aaron SH. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis. Can Respir J 2013; 20: 106-10. [CrossRef] Özkul S, Turna A, Demirkaya A, Aksoy B, Kaynak K. Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusi- ons: a prospective randomized controlled trial. J Thoracic Dis 2014; 6: 1731-5.
  2. Terra RM, Teixeira LR, Bibas BJ, Pego-Fernandes PM, Vargas FS, Jatene FB. Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status. Cli- nics (Sao Paulo) 2011; 66: 211-6. [CrossRef] Bhatnagar R, Laskawiec-Szkonter M, Piotrowska HE, Kahan BC, Hoo- per CE, Davies HE, et al. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): pro- tocol of an open-label randomised controlled trial. BMJ Open 2014; 4: e007045. [CrossRef] Gawron G, Gabrys J, Barczyk A. Talc slurry pleurodesis via chest tube in department of pulmonology - a 24-case study. Pneumonol Alergol Pol 2013; 81: 439-47.
  3. Agarwal R, Khan A, Aggarwal AN, Gupta D. Efficacy & safety of iodopo- vidone pleurodesis: a systematic review & meta-analysis. Indian J Med Res 2012; 135: 297-304.
  4. Ibrahim IM, Dokhan AL, El-Sessy AA, Eltaweel MF. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malig- nant pleural effusion. J Cardiothorac Surg 2015; 10: 64. [CrossRef] Fysh ETH, Thomas R, Read CA, Lam BCH, Yap E, Horwood FC, et al. Pro- tocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis. BMJ Open 2014; 4: e006757. [CrossRef] Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369: 1535-9. [CrossRef] Gammie JS, Banks MC, Fuhrman CR, Pham SM, Griffith BR, Keenan RJ, et al. The pigtail catheter for pleural drainage: a less invasive alternati- ve to tube thoracostomy. JSLS 1999; 3: 57-61.